Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06188260
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2023-12-18
Brief Title:
Efficacy of a New Nanoemulsion Artificial Tear in Dry Eye Disease Management
Sponsor:
The Hong Kong Polytechnic University
Organization:
The Hong Kong Polytechnic University
Study Overview
Official Title:
Efficacy of a New Nanoemulsion Artificial Tear in Dry Eye Disease Management
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective cohort study to compare subjective changes in symptoms using the Ocular Surface Disease Index OSDI questionnaire following the recommended dosage of the new nanoemulsion eye drops Systane Completein mild to moderate dry eye patients and to investigate objective ocular surface changes using modern clinical instruments during the study period
Detailed Description:
This study lasting for 3 months in total is to investigate the changes in both subjective reports OSDI score and objective measurements Non-invasive Tear Break Time NITBUT and other clinical signs such as corneal staining after the use of this nanoemulsion eye drops Systane Complete Subjects are required to use the eyedrop qid for 3 months and come back for follow-up at 2-week and 3-month visits Other secondary measurements such as Meibography and lipid layer thickness will also be investigated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None